Global Cancer Diagnostics Industry

Global Cancer Diagnostics Market to Reach $223. 3 Billion by 2027. Amid the COVID-19 crisis, the global market for Cancer Diagnostics estimated at US$150. 6 Billion in the year 2020, is projected to reach a revised size of US$223.

New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cancer Diagnostics Industry" - https://www.reportlinker.com/p05956209/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Laboratory Tests, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$50.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Tests segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $40.8 Billion, While China is Forecast to Grow at 8.8% CAGR

The Cancer Diagnostics market in the U.S. is estimated at US$40.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$46.7 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Imaging Segment to Record 6.2% CAGR

In the global Imaging segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.4 Billion in the year 2020 will reach a projected size of US$41.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$30.1 Billion by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 308-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Abbott Diagnostics

• Abbott Laboratories

• Agilent Technologies, Inc.

• Ambry Genetics Corporation

• Applied Imaging

• AstraZeneca PLC

• AutoGenomics, Inc.

• BARD, A Becton, Dickinson Company

• Bayer AG

• Becton, Dickinson and Company

• BioCurex, Inc.

• bioMeriux SA

• Celara Diagnostics

• Diagnostic Products Corporation

• Eli Lilly and Company

• F. Hoffmann-La Roche AG

• GE Healthcare

• Genoptix, Inc.

• GlaxoSmithKline PLC

• Hologic, Inc.

• Illumina, Inc.

• Pfizer, Inc.

• Philips Healthcare

• QIAGEN GmbH

• Siemens Healthineers

• Thermo Fisher Scientific, Inc.

Read the full report: https://www.reportlinker.com/p05956209/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Cancer Diagnostics Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Cancer Diagnostics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Cancer Diagnostics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Cancer Diagnostics Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Laboratory Tests (Type) World Market by Region/Country
in US$ Million: 2020 to 2027

Table 5: Laboratory Tests (Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Laboratory Tests (Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Genetic Tests (Type) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 8: Genetic Tests (Type) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019

Table 9: Genetic Tests (Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Imaging (Type) Geographic Market Spread Worldwide in
US$ Million: 2020 to 2027

Table 11: Imaging (Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019

Table 12: Imaging (Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Endoscopy (Type) World Market Estimates and Forecasts
by Region/Country in US$ Million: 2020 to 2027

Table 14: Endoscopy (Type) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019

Table 15: Endoscopy (Type) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

Table 16: Biopsy (Type) World Market by Region/Country in US$
Million: 2020 to 2027

Table 17: Biopsy (Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 18: Biopsy (Type) Market Share Distribution in Percentage
by Region/Country: 2012 VS 2020 VS 2027

Table 19: Other Types (Type) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2020 to 2027

Table 20: Other Types (Type) Market Worldwide Historic Review
by Region/Country in US$ Million: 2012 to 2019

Table 21: Other Types (Type) Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027

Table 22: Breast (Application) Global Opportunity Assessment in
US$ Million by Region/Country: 2020-2027

Table 23: Breast (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019

Table 24: Breast (Application) Percentage Share Breakdown of
Global Sales by Region/Country: 2012 VS 2020 VS 2027

Table 25: Lung (Application) Worldwide Sales in US$ Million by
Region/Country: 2020-2027

Table 26: Lung (Application) Historic Demand Patterns in US$
Million by Region/Country: 2012-2019

Table 27: Lung (Application) Market Share Shift across Key
Geographies: 2012 VS 2020 VS 2027

Table 28: Colorectal (Application) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027

Table 29: Colorectal (Application) Retrospective Demand
Analysis in US$ Million by Region/Country: 2012-2019

Table 30: Colorectal (Application) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

Table 31: Skin (Application) Demand Potential Worldwide in US$
Million by Region/Country: 2020-2027

Table 32: Skin (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019

Table 33: Skin (Application) Share Breakdown Review by
Region/Country: 2012 VS 2020 VS 2027

Table 34: Prostate (Application) Worldwide Latent Demand
Forecasts in US$ Million by Region/Country: 2020-2027

Table 35: Prostate (Application) Global Historic Analysis in
US$ Million by Region/Country: 2012-2019

Table 36: Prostate (Application) Distribution of Global Sales
by Region/Country: 2012 VS 2020 VS 2027

Table 37: Blood (Application) Sales Estimates and Forecasts in
US$ Million by Region/Country for the Years 2020 through 2027

Table 38: Blood (Application) Analysis of Historic Sales in US$
Million by Region/Country for the Years 2012 to 2019

Table 39: Blood (Application) Global Market Share Distribution
by Region/Country for 2012, 2020, and 2027

Table 40: Ovarian (Application) Global Opportunity Assessment
in US$ Million by Region/Country: 2020-2027

Table 41: Ovarian (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019

Table 42: Ovarian (Application) Percentage Share Breakdown of
Global Sales by Region/Country: 2012 VS 2020 VS 2027

Table 43: Other Applications (Application) Worldwide Sales in
US$ Million by Region/Country: 2020-2027

Table 44: Other Applications (Application) Historic Demand
Patterns in US$ Million by Region/Country: 2012-2019

Table 45: Other Applications (Application) Market Share Shift
across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Cancer Diagnostics Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 46: United States Cancer Diagnostics Market Estimates and
Projections in US$ Million by Type: 2020 to 2027

Table 47: Cancer Diagnostics Market in the United States by
Type: A Historic Review in US$ Million for 2012-2019

Table 48: United States Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027

Table 49: United States Cancer Diagnostics Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 50: Cancer Diagnostics Historic Demand Patterns in the
United States by Application in US$ Million for 2012-2019

Table 51: Cancer Diagnostics Market Share Breakdown in the
United States by Application: 2012 VS 2020 VS 2027

CANADA
Table 52: Canadian Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027

Table 53: Canadian Cancer Diagnostics Historic Market Review by
Type in US$ Million: 2012-2019

Table 54: Cancer Diagnostics Market in Canada: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027

Table 55: Canadian Cancer Diagnostics Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027

Table 56: Cancer Diagnostics Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019

Table 57: Canadian Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027

JAPAN
Table 58: Japanese Market for Cancer Diagnostics: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2020-2027

Table 59: Cancer Diagnostics Market in Japan: Historic Sales
Analysis in US$ Million by Type for the Period 2012-2019

Table 60: Japanese Cancer Diagnostics Market Share Analysis by
Type: 2012 VS 2020 VS 2027

Table 61: Japanese Demand Estimates and Forecasts for Cancer
Diagnostics in US$ Million by Application: 2020 to 2027

Table 62: Japanese Cancer Diagnostics Market in US$ Million by
Application: 2012-2019

Table 63: Cancer Diagnostics Market Share Shift in Japan by
Application: 2012 VS 2020 VS 2027

CHINA
Table 64: Chinese Cancer Diagnostics Market Growth Prospects in
US$ Million by Type for the Period 2020-2027

Table 65: Cancer Diagnostics Historic Market Analysis in China
in US$ Million by Type: 2012-2019

Table 66: Chinese Cancer Diagnostics Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027

Table 67: Chinese Demand for Cancer Diagnostics in US$ Million
by Application: 2020 to 2027

Table 68: Cancer Diagnostics Market Review in China in US$
Million by Application: 2012-2019

Table 69: Chinese Cancer Diagnostics Market Share Breakdown by
Application: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Cancer Diagnostics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 70: European Cancer Diagnostics Market Demand Scenario in
US$ Million by Region/Country: 2020-2027

Table 71: Cancer Diagnostics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 72: European Cancer Diagnostics Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 73: European Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020-2027

Table 74: Cancer Diagnostics Market in Europe in US$ Million by
Type: A Historic Review for the Period 2012-2019

Table 75: European Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027

Table 76: European Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 77: Cancer Diagnostics Market in Europe: Summarization of
Historic Demand in US$ Million by Application for the Period
2012-2019

Table 78: European Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027

FRANCE
Table 79: Cancer Diagnostics Market in France by Type:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 80: French Cancer Diagnostics Historic Market Scenario in
US$ Million by Type: 2012-2019

Table 81: French Cancer Diagnostics Market Share Analysis by
Type: 2012 VS 2020 VS 2027

Table 82: Cancer Diagnostics Quantitative Demand Analysis in
France in US$ Million by Application: 2020-2027

Table 83: French Cancer Diagnostics Historic Market Review in
US$ Million by Application: 2012-2019

Table 84: French Cancer Diagnostics Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027

GERMANY
Table 85: Cancer Diagnostics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027

Table 86: German Cancer Diagnostics Historic Market Analysis in
US$ Million by Type: 2012-2019

Table 87: German Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027

Table 88: Cancer Diagnostics Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027

Table 89: German Cancer Diagnostics Market in Retrospect in US$
Million by Application: 2012-2019

Table 90: Cancer Diagnostics Market Share Distribution in
Germany by Application: 2012 VS 2020 VS 2027

ITALY
Table 91: Italian Cancer Diagnostics Market Growth Prospects in
US$ Million by Type for the Period 2020-2027

Table 92: Cancer Diagnostics Historic Market Analysis in Italy
in US$ Million by Type: 2012-2019

Table 93: Italian Cancer Diagnostics Market by Type: Percentage
Breakdown of Sales for 2012, 2020, and 2027

Table 94: Italian Demand for Cancer Diagnostics in US$ Million
by Application: 2020 to 2027

Table 95: Cancer Diagnostics Market Review in Italy in US$
Million by Application: 2012-2019

Table 96: Italian Cancer Diagnostics Market Share Breakdown by
Application: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 97: United Kingdom Market for Cancer Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Type for the
Period 2020-2027

Table 98: Cancer Diagnostics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Type for the Period
2012-2019

Table 99: United Kingdom Cancer Diagnostics Market Share
Analysis by Type: 2012 VS 2020 VS 2027

Table 100: United Kingdom Demand Estimates and Forecasts for
Cancer Diagnostics in US$ Million by Application: 2020 to 2027

Table 101: United Kingdom Cancer Diagnostics Market in US$
Million by Application: 2012-2019

Table 102: Cancer Diagnostics Market Share Shift in the United
Kingdom by Application: 2012 VS 2020 VS 2027

SPAIN
Table 103: Spanish Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027

Table 104: Spanish Cancer Diagnostics Historic Market Review by
Type in US$ Million: 2012-2019

Table 105: Cancer Diagnostics Market in Spain: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027

Table 106: Spanish Cancer Diagnostics Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027

Table 107: Cancer Diagnostics Market in Spain: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019

Table 108: Spanish Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027

RUSSIA
Table 109: Russian Cancer Diagnostics Market Estimates and
Projections in US$ Million by Type: 2020 to 2027

Table 110: Cancer Diagnostics Market in Russia by Type:
A Historic Review in US$ Million for 2012-2019

Table 111: Russian Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027

Table 112: Russian Cancer Diagnostics Latent Demand Forecasts
in US$ Million by Application: 2020 to 2027

Table 113: Cancer Diagnostics Historic Demand Patterns in
Russia by Application in US$ Million for 2012-2019

Table 114: Cancer Diagnostics Market Share Breakdown in Russia
by Application: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 115: Rest of Europe Cancer Diagnostics Market Estimates
and Forecasts in US$ Million by Type: 2020-2027

Table 116: Cancer Diagnostics Market in Rest of Europe in US$
Million by Type: A Historic Review for the Period 2012-2019

Table 117: Rest of Europe Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027

Table 118: Rest of Europe Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 119: Cancer Diagnostics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 120: Rest of Europe Cancer Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 121: Asia-Pacific Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 122: Cancer Diagnostics Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2012-2019

Table 123: Asia-Pacific Cancer Diagnostics Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 124: Cancer Diagnostics Market in Asia-Pacific by Type:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 125: Asia-Pacific Cancer Diagnostics Historic Market
Scenario in US$ Million by Type: 2012-2019

Table 126: Asia-Pacific Cancer Diagnostics Market Share
Analysis by Type: 2012 VS 2020 VS 2027

Table 127: Cancer Diagnostics Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2020-2027

Table 128: Asia-Pacific Cancer Diagnostics Historic Market
Review in US$ Million by Application: 2012-2019

Table 129: Asia-Pacific Cancer Diagnostics Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

AUSTRALIA
Table 130: Cancer Diagnostics Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027

Table 131: Australian Cancer Diagnostics Historic Market
Analysis in US$ Million by Type: 2012-2019

Table 132: Australian Cancer Diagnostics Market Share Breakdown
by Type: 2012 VS 2020 VS 2027

Table 133: Cancer Diagnostics Market in Australia: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027

Table 134: Australian Cancer Diagnostics Market in Retrospect
in US$ Million by Application: 2012-2019

Table 135: Cancer Diagnostics Market Share Distribution in
Australia by Application: 2012 VS 2020 VS 2027

INDIA
Table 136: Indian Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020 to 2027

Table 137: Indian Cancer Diagnostics Historic Market Review by
Type in US$ Million: 2012-2019

Table 138: Cancer Diagnostics Market in India: Percentage Share
Breakdown of Sales by Type for 2012, 2020, and 2027

Table 139: Indian Cancer Diagnostics Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027

Table 140: Cancer Diagnostics Market in India: Summarization of
Historic Demand Patterns in US$ Million by Application for
2012-2019

Table 141: Indian Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 142: Cancer Diagnostics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Type for
the Period 2020-2027

Table 143: South Korean Cancer Diagnostics Historic Market
Analysis in US$ Million by Type: 2012-2019

Table 144: Cancer Diagnostics Market Share Distribution in
South Korea by Type: 2012 VS 2020 VS 2027

Table 145: Cancer Diagnostics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Application
for the Period 2020-2027

Table 146: South Korean Cancer Diagnostics Historic Market
Analysis in US$ Million by Application: 2012-2019

Table 147: Cancer Diagnostics Market Share Distribution in
South Korea by Application: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 148: Rest of Asia-Pacific Market for Cancer Diagnostics:
Annual Sales Estimates and Projections in US$ Million by Type
for the Period 2020-2027

Table 149: Cancer Diagnostics Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Type for the Period
2012-2019

Table 150: Rest of Asia-Pacific Cancer Diagnostics Market Share
Analysis by Type: 2012 VS 2020 VS 2027

Table 151: Rest of Asia-Pacific Demand Estimates and Forecasts
for Cancer Diagnostics in US$ Million by Application: 2020 to
2027

Table 152: Rest of Asia-Pacific Cancer Diagnostics Market in
US$ Million by Application: 2012-2019

Table 153: Cancer Diagnostics Market Share Shift in Rest of
Asia-Pacific by Application: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 154: Latin American Cancer Diagnostics Market Trends by
Region/Country in US$ Million: 2020-2027

Table 155: Cancer Diagnostics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2012-2019

Table 156: Latin American Cancer Diagnostics Market Percentage
Breakdown of Sales by Region/Country: 2012, 2020, and 2027

Table 157: Latin American Cancer Diagnostics Market Growth
Prospects in US$ Million by Type for the Period 2020-2027

Table 158: Cancer Diagnostics Historic Market Analysis in Latin
America in US$ Million by Type: 2012-2019

Table 159: Latin American Cancer Diagnostics Market by Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 160: Latin American Demand for Cancer Diagnostics in US$
Million by Application: 2020 to 2027

Table 161: Cancer Diagnostics Market Review in Latin America in
US$ Million by Application: 2012-2019

Table 162: Latin American Cancer Diagnostics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

ARGENTINA
Table 163: Argentinean Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020-2027

Table 164: Cancer Diagnostics Market in Argentina in US$
Million by Type: A Historic Review for the Period 2012-2019

Table 165: Argentinean Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027

Table 166: Argentinean Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 167: Cancer Diagnostics Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 168: Argentinean Cancer Diagnostics Market Share Analysis
by Application: 2012 VS 2020 VS 2027

BRAZIL
Table 169: Cancer Diagnostics Market in Brazil by Type:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 170: Brazilian Cancer Diagnostics Historic Market
Scenario in US$ Million by Type: 2012-2019

Table 171: Brazilian Cancer Diagnostics Market Share Analysis
by Type: 2012 VS 2020 VS 2027

Table 172: Cancer Diagnostics Quantitative Demand Analysis in
Brazil in US$ Million by Application: 2020-2027

Table 173: Brazilian Cancer Diagnostics Historic Market Review
in US$ Million by Application: 2012-2019

Table 174: Brazilian Cancer Diagnostics Market Share Analysis:
A 17-Year Perspective by Application for 2012, 2020, and 2027

MEXICO
Table 175: Cancer Diagnostics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2020-2027

Table 176: Mexican Cancer Diagnostics Historic Market Analysis
in US$ Million by Type: 2012-2019

Table 177: Mexican Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027

Table 178: Cancer Diagnostics Market in Mexico: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027

Table 179: Mexican Cancer Diagnostics Market in Retrospect in
US$ Million by Application: 2012-2019

Table 180: Cancer Diagnostics Market Share Distribution in
Mexico by Application: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 181: Rest of Latin America Cancer Diagnostics Market
Estimates and Projections in US$ Million by Type: 2020 to 2027

Table 182: Cancer Diagnostics Market in Rest of Latin America
by Type: A Historic Review in US$ Million for 2012-2019

Table 183: Rest of Latin America Cancer Diagnostics Market
Share Breakdown by Type: 2012 VS 2020 VS 2027

Table 184: Rest of Latin America Cancer Diagnostics Latent
Demand Forecasts in US$ Million by Application: 2020 to 2027

Table 185: Cancer Diagnostics Historic Demand Patterns in Rest
of Latin America by Application in US$ Million for 2012-2019

Table 186: Cancer Diagnostics Market Share Breakdown in Rest of
Latin America by Application: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 187: The Middle East Cancer Diagnostics Market Estimates
and Forecasts in US$ Million by Region/Country: 2020-2027

Table 188: Cancer Diagnostics Market in the Middle East by
Region/Country in US$ Million: 2012-2019

Table 189: The Middle East Cancer Diagnostics Market Share
Breakdown by Region/Country: 2012, 2020, and 2027

Table 190: The Middle East Cancer Diagnostics Market Estimates
and Forecasts in US$ Million by Type: 2020 to 2027

Table 191: The Middle East Cancer Diagnostics Historic Market
by Type in US$ Million: 2012-2019

Table 192: Cancer Diagnostics Market in the Middle East:
Percentage Share Breakdown of Sales by Type for 2012,2020, and
2027

Table 193: The Middle East Cancer Diagnostics Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 194: Cancer Diagnostics Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 195: The Middle East Cancer Diagnostics Market Share
Analysis by Application: 2012 VS 2020 VS 2027

IRAN
Table 196: Iranian Market for Cancer Diagnostics: Annual Sales
Estimates and Projections in US$ Million by Type for the Period
2020-2027

Table 197: Cancer Diagnostics Market in Iran: Historic Sales
Analysis in US$ Million by Type for the Period 2012-2019

Table 198: Iranian Cancer Diagnostics Market Share Analysis by
Type: 2012 VS 2020 VS 2027

Table 199: Iranian Demand Estimates and Forecasts for Cancer
Diagnostics in US$ Million by Application: 2020 to 2027

Table 200: Iranian Cancer Diagnostics Market in US$ Million by
Application: 2012-2019

Table 201: Cancer Diagnostics Market Share Shift in Iran by
Application: 2012 VS 2020 VS 2027

ISRAEL
Table 202: Israeli Cancer Diagnostics Market Estimates and
Forecasts in US$ Million by Type: 2020-2027

Table 203: Cancer Diagnostics Market in Israel in US$ Million
by Type: A Historic Review for the Period 2012-2019

Table 204: Israeli Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027

Table 205: Israeli Cancer Diagnostics Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 206: Cancer Diagnostics Market in Israel: Summarization
of Historic Demand in US$ Million by Application for the Period
2012-2019

Table 207: Israeli Cancer Diagnostics Market Share Analysis by
Application: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 208: Saudi Arabian Cancer Diagnostics Market Growth
Prospects in US$ Million by Type for the Period 2020-2027

Table 209: Cancer Diagnostics Historic Market Analysis in Saudi
Arabia in US$ Million by Type: 2012-2019

Table 210: Saudi Arabian Cancer Diagnostics Market by Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 211: Saudi Arabian Demand for Cancer Diagnostics in US$
Million by Application: 2020 to 2027

Table 212: Cancer Diagnostics Market Review in Saudi Arabia in
US$ Million by Application: 2012-2019

Table 213: Saudi Arabian Cancer Diagnostics Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

UNITED ARAB EMIRATES
Table 214: Cancer Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Type for the Period 2020-2027

Table 215: United Arab Emirates Cancer Diagnostics Historic
Market Analysis in US$ Million by Type: 2012-2019

Table 216: Cancer Diagnostics Market Share Distribution in
United Arab Emirates by Type: 2012 VS 2020 VS 2027

Table 217: Cancer Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2020-2027

Table 218: United Arab Emirates Cancer Diagnostics Historic
Market Analysis in US$ Million by Application: 2012-2019

Table 219: Cancer Diagnostics Market Share Distribution in
United Arab Emirates by Application: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 220: Cancer Diagnostics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Type
for the Period 2020-2027

Table 221: Rest of Middle East Cancer Diagnostics Historic
Market Analysis in US$ Million by Type: 2012-2019

Table 222: Rest of Middle East Cancer Diagnostics Market Share
Breakdown by Type: 2012 VS 2020 VS 2027

Table 223: Cancer Diagnostics Market in Rest of Middle East:
Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 224: Rest of Middle East Cancer Diagnostics Market in
Retrospect in US$ Million by Application: 2012-2019

Table 225: Cancer Diagnostics Market Share Distribution in Rest
of Middle East by Application: 2012 VS 2020 VS 2027

AFRICA
Table 226: African Cancer Diagnostics Market Estimates and
Projections in US$ Million by Type: 2020 to 2027

Table 227: Cancer Diagnostics Market in Africa by Type:
A Historic Review in US$ Million for 2012-2019

Table 228: African Cancer Diagnostics Market Share Breakdown by
Type: 2012 VS 2020 VS 2027

Table 229: African Cancer Diagnostics Latent Demand Forecasts
in US$ Million by Application: 2020 to 2027

Table 230: Cancer Diagnostics Historic Demand Patterns in
Africa by Application in US$ Million for 2012-2019

Table 231: Cancer Diagnostics Market Share Breakdown in Africa
by Application: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 47
Read the full report: https://www.reportlinker.com/p05956209/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001